Founded in 1999
Myrexis, Inc. (formerly Myriad Pharmaceuticals, Inc.) is a biotechnology company focused on discovering, developing, and commercializing novel therapies for the treatment of cancer. Our pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemic...